Imarx Therapeutics, Inc.
12277 134th NE
Suite 202
Redmond,
WA 98052
United States - Map
Phone: 425-821-5501
Fax: 425-821-1404
Web Site: http://www.imarx.com
| ImaRx Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the development of therapies for stroke and other vascular disorders, using its microbubble technology. Its lead program, SonoLysis, involves the administration of its MRX-801 microspheres and ultrasound to break up blood clots and restore blood flow to oxygen deprived tissues. The company was founded in 1999 and is based in Redmond, Washington. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Reena Zutshi Ph.D., 41
VP of Operations |
N/A
| N/A | Dr. Garen Manvelian M.D., 45
Chief Medical Officer and VP of Clinical Devel. |
N/A
| N/A | Mr. John McCambridge , 60
VP of Sales & Marketing |
N/A
| N/A | Ms. Jennifer Marshall , 45
VP of Corp. Devel. |
N/A
| N/A | Dr. Terry Matsunaga PharmD, PhD, 55
VP of Research |
$
140.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-05
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.26% Nasdaq 0.00%
Profile
